Arteriocyte Research & Development Helping Patients Heal Faster™
Corporate Homepage

References

1.Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials, 27(36): 6043-6051

2. Ex Vivo Nanofiber Expansion and Genetic Modification of Human Cord Blood-Derived Progenitor/Stem Cells Enhances Vasculogenesis. Cell Transplant, 18(3): 305-318

3. Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model. PLoS One, 4(10): e7325

4. Hematopoietic Stem Cells: Ex Vivo Expansion and Therapeutic Potential for Myocardial Ischemia. Stem Cells and Cloning: Advances and Applications, 2010(3): 57-68

5. Expansion of Hematopoietic Stem Cells. Genetic Engineering News, 30 (16): 50 - 5

6. Expansion and Characterization of Cord Blood-Derived CD34+ Cells on NANEX™ 3D Nanofiber Scaffold. The International Society of Stem Cell Research 9th Annual Meeting, 2011

 

  Arteriocyte, Inc.

  Locations:

  Ohio Offices
  Cleveland
  Research & Development Center
  7100 Euclid Avenue
  Cleveland, Ohio 44103, USA
  Phone: 216-456-9640
 

  Massachusetts Offices
  Hopkinton
  Eastern US Manufacturing
  and Distribution Center
  45 South Street
  Hopkinton, MA 01748, USA
  Phone: 508-497-8950

  Utah Offices
  Salt Lake City
  Tissue Engineering Center
  1413 Center Drive, Ste 220
  Park City, UT 84098, USA
  Phone: 866-660-2674

  Maryland Offices
  Towson
  Malaria Initiative Center
  400 East Joppa Road
  Suite 416
  Towson, MD 21286, USA
  Phone: 866-660-2674

  E-mail: info@arteriocyte.com
  Phone: 1-866-660-AMSI(2674)
  Fax: 1-216-456-9641

Copyright© 2004-2012 Arteriocyte, Inc. All rights reserved.